Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis opens animal health books to Bayer, others - sources
Yahoo/Reuters
Tuesday, December 3, 2013 - 9:29am
tags:
Novartis, animal health, Bayer, M&A
Lexicon Completes Phase 2 Study Of LX1033 In IBS-d
Yahoo
Tuesday, December 3, 2013 - 9:26am
tags:
Lexicon Pharmaceuticals, IBS-d, LX1033
2 Biotech Stocks Facing Major Catalysts in 2014
Wall St Cheat Sheet
Tuesday, December 3, 2013 - 9:23am
tags:
Lion Biotechnologies, Chelsea Therapeutics, Northera, metastatic melanoma
Idenix fires off a shot in patent battle over Gilead's sofosbuvir
Fierce Biotech
Monday, December 2, 2013 - 5:04pm
tags:
Idenix, Gilead, sofosbuvir, hepatitis C
More Pharma Jobs Are Disappearing: Forest And Eisai Cut Back
Pharmalot
Monday, December 2, 2013 - 5:01pm
tags:
layoffs, Eisai, Forest Labs
Merck Faces Off Against Bristol-Myers' Yervoy
Motley Fool
Monday, December 2, 2013 - 5:00pm
tags:
Yervoy, Bristol-Myers Squibb, MK-3475, melanoma
Glivec Generics May Be Delayed In The U.S. - Buy Novartis
Seeking Alpha
Monday, December 2, 2013 - 4:58pm
tags:
Glivec, generics, Novartis, chronic myeloid leukemia
Why Did These 3 Biotechs Fail to Rally?
Motley Fool
Monday, December 2, 2013 - 4:57pm
tags:
Incyte, Questcor Pharmaceuticals, Acthar, Techne
4 Top-Performing Biotech IPOs of 2013
Minyanville
Monday, December 2, 2013 - 4:55pm
tags:
IPOs, biotech, INSYS Therapeutics, GW Pharma, Aratana, Alcobra
AIDS Group Sues Abbott And AbbVie Over 340B Drug Discounts
Pharmalot
Monday, December 2, 2013 - 11:49am
tags:
AIDS, Abbott Labs, 340B, AbbVie
PharmAthene scraps Theraclone merger after feds nix funding
Fierce Biotech
Monday, December 2, 2013 - 11:46am
tags:
PharmAthene, M&A, Theraclone
HeartWare buys CircuLite for up to $350M
Mass Device
Monday, December 2, 2013 - 11:45am
tags:
devices, Circulite, HeartWare, M&A
Arena's Belviq Script Sales Hit Milestones
Seeking Alpha
Monday, December 2, 2013 - 11:39am
tags:
Belviq, Eisai, Arena Pharmaceuticals
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Yahoo
Monday, December 2, 2013 - 10:17am
tags:
Saphris, schizophrenia, Forest Labs, Merck
Biogen Idec says FDA will allow 3 more months to review its hemophilia B drug Alprolix
Yahoo/AP
Monday, December 2, 2013 - 10:15am
tags:
Biogen Idec, FDA, hemophilia B, Alprolix
Baxter submits amended BLA to U.S. FDA for HyQvia
The Fly on the Wall
Monday, December 2, 2013 - 10:13am
tags:
Baxter International, FDA, HyQvia, Halozyme
Forest Labs Unveils Restructuring Plan
NASDAQ.com
Monday, December 2, 2013 - 9:51am
tags:
Forest Labs, restructuring, layoffs
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Monday, December 2, 2013 - 9:45am
tags:
JNJ, Remicade, Olysio, hepatitis C
Is GlaxoSmithKline plc Set For Electrifying Earnings Growth In 2014?
Motley Fool
Monday, December 2, 2013 - 9:43am
tags:
GSK
The Growing Need For Outcome Studies And The Impact On R&D Costs
Forbes
Monday, December 2, 2013 - 9:42am
tags:
clinical outcomes, R&D, PCSK9 inhibitors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.